PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Genetic predisposition to schizophrenia may increase risk of psychosis from cannabis use

2021-04-13
(Press-News.org) It has been long been known that cannabis users develop psychosis more often than non-users, but what is still not fully clear is whether cannabis actually causes psychosis and, if so, who is most at risk. A new study published in Translational Psychiatry by researchers at the Centre for Addiction and Mental Health (CAMH) and King's College London helps shed light on both questions. The research shows that while cannabis users had higher rates of psychotic experiences than non-users across the board, the difference was especially pronounced among those with high genetic predisposition to schizophrenia.

"These results are significant because they're the first evidence we've seen that people genetically prone to psychosis might be disproportionately affected by cannabis," said lead author Dr. Michael Wainberg, Scientist the Krembil Centre for Neuroinformatics at CAMH. "And because genetic risk scoring is still in its early days, the true influence of genetics on the cannabis-psychosis relationship may be even greater than what we found here."

Using data from the UK Biobank, a large-scale biomedical database containing participants' in-depth genetic and health information, the authors analyzed the relationship between genetics, cannabis use and psychotic experiences across more than 100,000 people. Each person reported their frequency of past cannabis use, and whether they had ever had various types of psychotic experiences, such as auditory or visual hallucinations. The researchers also scored each person's genetic risk for schizophrenia, by looking at which of their DNA mutations were more common among schizophrenia patients than among the general population.

Overall, people who had used cannabis were 50 per cent more likely to report psychotic experiences than people who had not. However, this increase was not uniform across the study group: among the fifth of participants with the highest genetic risk scores for schizophrenia, it was 60 per cent, and among the fifth with the lowest scores, it was only 40 per cent. In other words, people genetically predisposed to schizophrenia were at disproportionately higher risk for psychotic experiences if they also had a history of cannabis use.

Notably, because much less is known about the genetics of schizophrenia in non-white populations, the study's analysis was limited to self-reported white participants. "This study, while limited in scope, is an important step forward in understanding how cannabis use and genetics may interact to influence psychosis risk," added senior author Dr. Shreejoy Tripathy, Independent Scientist at the Krembil Centre for Neuroinformatics, who supervised the study. "The more we know about the connection between cannabis and psychosis, the more we can inform the public about the potential risks of using this substance. This research offers a window into a future where genetics can help empower individuals to make more informed decisions about drug use."

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Study suggests common drug could be used to prevent certain skin cancers

2021-04-13
COLUMBUS, Ohio ¬- New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun. While this data was gathered from preclinical studies, senior author Sujit Basu, MD, PhD, says preliminary results in animal models are very promising and worthy of immediate further investigation through phase I human studies. ...

Combining mask wearing, social distancing suppresses COVID-19 virus spread

2021-04-13
Studies show wearing masks and social distancing can contain the spread of the COVID-19 virus, but their combined effectiveness is not precisely known. In Chaos, by AIP Publishing, researchers at New York University Tandon School of Engineering and Politecnico di Torino in Italy developed a network model to study the effects of these two measures on the spread of airborne diseases like COVID-19. The model shows viral outbreaks can be prevented if at least 60% of a population complies with both measures. "Neither social distancing nor mask wearing alone are likely sufficient to halt the spread of COVID-19, unless almost the entire population adheres to the single measure," author Maurizio Porfiri said. "But if a significant fraction of the ...

Atom interferometry demonstrated in space for the first time

Atom interferometry demonstrated in space for the first time
2021-04-13
Extremely precise measurements are possible using atom interferometers that employ the wave character of atoms for this purpose. They can thus be used, for example, to measure the gravitational field of the Earth or to detect gravitational waves. A team of scientists from Germany has now managed to successfully perform atom interferometry in space for the first time - on board a sounding rocket. "We have established the technological basis for atom interferometry on board of a sounding rocket and demonstrated that such experiments are not only possible on Earth, but also in space," said Professor Patrick Windpassinger of the Institute of Physics at Johannes Gutenberg University Mainz (JGU), whose team was involved in the investigation. The results of their analyses have been ...

New assay detects marker of metastatic cancers, infection, trauma and neurological disease

2021-04-13
Scientists at the Walter Reed Army Institute for Research demonstrated the potential of a novel blood test for cathepsin B, a well-studied protein important to brain development and function, as an indicator for a range of disease states. Cathepsin B plays an important role in the body, regulating the metabolism, immune responses, degradation of improperly produced proteins and other functions. Under certain conditions, such as metastatic cancers, infections, trauma and neurological disease, cathepsin B production is upregulated. Recent research published by WRAIR researchers highlighted the potential of cathepsin B as an indicator, or biomarker, of the severity of traumatic brain injury. In this study, published in ACS Omega, researchers demonstrated an ultrasensitive ...

No batteries? No sweat! Wearable biofuel cells now produce electricity from lactate

2021-04-13
It cannot be denied that, over the past few decades, the miniaturization of electronic devices has taken huge strides. Today, after pocket-size smartphones that could put old desktop computers to shame and a plethora of options for wireless connectivity, there is a particular type of device whose development has been steadily advancing: wearable biosensors. These tiny devices are generally meant to be worn directly on the skin in order to measure specific biosignals and, by sending measurements wirelessly to smartphones or computers, keep track of the user's health. Although materials scientists have developed many types ...

Researchers streamline molecular assembly line to design, test drug compounds

2021-04-13
Researchers from North Carolina State University have found a way to fine-tune the molecular assembly line that creates antibiotics via engineered biosynthesis. The work could allow scientists to improve existing antibiotics as well as design new drug candidates quickly and efficiently. Bacteria - such as E. coli - harness biosynthesis to create molecules that are difficult to make artificially. "We already use bacteria to make a number of drugs for us," says Edward Kalkreuter, former graduate student at NC State and lead author of a paper describing the ...

Psychedelic experience may not be required for psilocybin's antidepressant-like benefits

2021-04-13
University of Maryland School of Medicine (UMSOM) researchers have shown that psilocybin--the active chemical in "magic mushrooms"-- still works its antidepressant-like actions, at least in mice, even when the psychedelic experience is blocked. The new findings suggest that psychedelic drugs work in multiple ways in the brain and it may be possible to deliver the fast-acting antidepressant therapeutic benefit without requiring daylong guided therapy sessions. A version of the drug without, or with less of, the psychedelic effects could loosen restrictions on who could receive the therapy, and lower costs, making the benefits of psilocybin more available to more people in need. In all clinical ...

Novel theory addresses centuries-old physics problem

2021-04-13
The "three-body problem," the term coined for predicting the motion of three gravitating bodies in space, is essential for understanding a variety of astrophysical processes as well as a large class of mechanical problems, and has occupied some of the world's best physicists, astronomers and mathematicians for over three centuries. Their attempts have led to the discovery of several important fields of science; yet its solution remained a mystery. At the end of the 17th century, Sir Isaac Newton succeeded in explaining the motion of the planets around the sun through ...

JNCCN Study: Important potential role for routine brain imaging in advanced kidney cancer

JNCCN Study: Important potential role for routine brain imaging in advanced kidney cancer
2021-04-13
PLYMOUTH MEETING, PA [April 13, 2021] -- The April 2021 issue of JNCCN--Journal of the National Comprehensive Cancer Network publishes new research from Memorial Sloan Kettering Cancer Center (MSK) and Gustave Roussy Institute, which suggests that baseline brain imaging should be considered in most patients with metastatic kidney cancer. The researchers studied 1,689 patients with metastatic renal cell carcinoma (mRCC) who had been considered for clinical trial participation at either of the two institutions between 2001 and 2019 and had undergone brain imaging in this context, without clinical suspicion for brain involvement. The researchers discovered 4% had asymptomatic brain metastases in this setting. This group was found to have a low median 1-year ...

More exposure to political TV ads heightens anxiety

2021-04-13
ITHACA, N.Y. - We've all seen them: political ads on television that promise doom gloom if Candidate X is elected, and how all your problems will be solved if you choose Candidate Y. And Candidate Y, of course, approves this message. Beyond attempting to move a large swath of the population to vote one way or another, the seemingly constant bombardment of negativity in the name of our democratic process is anxiety-inducing, researchers have found. "Many of my friends and family members wind up quite stressed out, for lack of a better word, during each election season," said Jeff Niederdeppe, professor in the Department of Communication in the College of ...

LAST 30 PRESS RELEASES:

Existing drug has potential for immune paralysis

Soft brainstem implant delivers high-resolution hearing

Uncovering the structural and regulatory mechanisms underlying translation arrest

Scientists develop strategy to improve flexible tandem solar cell performance

Pushing boundaries: Detecting the anomalous Hall effect without magnetization in a new class of materials

Generative AI’s diagnostic capabilities comparable to non-specialist doctors

Some patients may experience durable disease control even after discontinuing immune checkpoint inhibitors for side effects

Native American names extend the earthquake history of northeastern North America

Lake deposits reveal directional shaking during devastating 1976 Guatemala earthquake

How wide are faults?

Key enzyme in lipid metabolism linked to immune system aging

Improved smoking cessation support needed for surgery patients across Europe

Study finds women much more likely to be aware of and have good understanding of obesity drugs

Study details role of protein that may play a key role in the development of schizophrenia

Americans don’t think bird flu is a threat, study suggests

New CDC report shows increase in autism in 2022 with notable shifts in race, ethnicity, and sex

Modulating the brain’s immune system may curb damage in Alzheimer’s

Laurie Manjikian named vice president of rehabilitation services and outpatient operations at Hebrew SeniorLife

Nonalcoholic beer yeasts evaluated for fermentation activity, flavor profiles

Millions could lose no-cost preventive services if SCOTUS upholds ruling

Research spotlight: Deer hunting season linked to rise in non-hunting firearm incidents

Rice scientists uncover quantum surprise: Matter mediates ultrastrong coupling between light particles

Integrative approach reveals promising candidates for Alzheimer’s disease risk factors or targets for therapeutic intervention

A wearable smart insole can track how you walk, run and stand

Research expands options for more sustainable soybean production

Global innovation takes center stage at Rice as undergraduate teams tackle health inequities

NIST's curved neutron beams could deliver benefits straight to industry

Finding friendship at first whiff: Scent plays role in platonic potential

Consortium of Multiple Sclerosis Centers releases 2025 expert panel document on best practices in MS management

A cool fix for hot chips: Advanced thermal management technology for electronic devices

[Press-News.org] Genetic predisposition to schizophrenia may increase risk of psychosis from cannabis use